The Discounted Cash Flow (DCF) valuation of Seres Therapeutics Inc (MCRB) is 7.79 USD. With the latest stock price at 3.52 USD, the upside of Seres Therapeutics Inc based on DCF is 121.2%.
Based on the latest price of 3.52 USD and our DCF valuation, Seres Therapeutics Inc (MCRB) is a buy. buying MCRB stocks now will result in a potential gain of 121.2%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 7.6% | 6.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 6.03 - 17.45 | 7.79 |
| Upside | 71.4% - 395.6% | 121.2% |